Multifocal Atrial Tachycardia Clinical Features ECG Diagnosis and Management
medicine

Multifocal Atrial Tachycardia Clinical Features ECG Diagnosis and Management

Jan 5, 2026 3 min read 15 MCQs included

Multifocal Atrial Tachycardia (MAT)

1. Definition

Multifocal atrial tachycardia (MAT) is a supraventricular tachyarrhythmia characterized by:

  • Irregular atrial rhythm
  • Heart rate > 100 beats/min
  • At least three distinct P-wave morphologies on ECG

It reflects multiple ectopic atrial pacemakers firing independently.

2. Epidemiology

  • Predominantly seen in elderly patients
  • Strongly associated with severe pulmonary disease
  • Common in hospitalized and critically ill patients

3. Pathophysiology

MAT results from enhanced atrial automaticity due to:

  • Hypoxemia → ↑ sympathetic tone
  • Hypercapnia and acidosis
  • Atrial stretch
  • Electrolyte disturbances

Multiple atrial foci compete with the sinus node → chaotic atrial depolarization → irregular ventricular response.

4. Common Causes and Triggers

Pulmonary Causes (most important)

  • Chronic obstructive pulmonary disease (COPD)
  • Acute exacerbation of asthma
  • Pneumonia
  • Pulmonary embolism
  • Respiratory failure

Cardiac Causes

  • Congestive heart failure
  • Ischemic heart disease
  • Valvular heart disease

Metabolic and Systemic Causes

  • Hypoxia
  • Hypokalemia
  • Hypomagnesemia
  • Sepsis
  • Renal failure

Drug-Related

  • Theophylline
  • Beta-agonists
  • Excess catecholamines

5. Clinical Features

Symptoms

  • Palpitations
  • Dyspnea
  • Fatigue
  • Lightheadedness
  • Worsening respiratory distress

Signs

  • Irregularly irregular pulse
  • Tachycardia
  • Features of underlying lung disease
  • Possible hypotension in severe cases

6. Electrocardiographic (ECG) Features

Diagnostic Criteria

  • Heart rate > 100/min
  • Irregularly irregular rhythm
  • ≥ 3 different P-wave morphologies
  • Variable PR intervals
  • Isoelectric baseline between P waves (helps distinguish from atrial fibrillation)

7. Differential Diagnosis

| Condition | Key Distinguishing Feature |

| ---------------------------------- | --------------------------------- |

| Atrial fibrillation | No distinct P waves |

| Atrial flutter with variable block | Sawtooth flutter waves |

| Sinus tachycardia with PACs | Single P-wave morphology |

| Wandering atrial pacemaker | Same ECG pattern but HR < 100/min |

8. Investigations

Essential

  • 12-lead ECG (diagnostic)
  • Pulse oximetry / ABG
  • Serum electrolytes (K⁺, Mg²⁺)
  • Chest X-ray
  • Renal function tests

Additional (if indicated)

  • Echocardiography
  • Cardiac biomarkers (if ischemia suspected)

9. Management (Stepwise and Definitive)

A. Treat the Underlying Cause (MOST IMPORTANT)

  • Correct hypoxia → oxygen therapy
  • Treat COPD/asthma exacerbation
  • Manage infection or sepsis
  • Correct electrolyte imbalance
  • Stop offending drugs (e.g., theophylline)

> MAT rarely resolves unless the underlying cause is corrected

B. Rate Control (if symptomatic or hemodynamically unstable)

1. Magnesium Sulfate

  • Indication: First-line therapy even if Mg²⁺ is normal
  • Mechanism: Stabilizes atrial myocardium and suppresses ectopic activity
  • Dose:

* IV 2 g over 10–15 minutes

  • Adverse Effects: Hypotension, flushing (rare)
  • Monitoring: Blood pressure, deep tendon reflexes

2. Calcium Channel Blockers (Preferred in COPD)

Verapamil or Diltiazem

  • Mechanism: Slows AV nodal conduction
  • Dose:

* Verapamil IV 2.5–5 mg slowly

* Diltiazem IV bolus followed by infusion

  • Contraindications: Severe LV dysfunction, hypotension
  • Adverse Effects: Bradycardia, hypotension

3. Beta-Blockers (Use with Caution)

  • Mechanism: Reduce sympathetic drive
  • Use: Only if no significant bronchospasm
  • Contraindications: Severe COPD, asthma

C. What NOT to Use

  • Digoxin: Ineffective
  • Electrical cardioversion: Ineffective (automatic focus arrhythmia)
  • Class I or III antiarrhythmics: Not recommended

10. Anticoagulation

  • Not indicated
  • Unlike atrial fibrillation, MAT does not increase thromboembolic risk

11. Prognosis

  • MAT itself is not usually fatal
  • Prognosis depends on the underlying disease
  • High in-hospital mortality reflects severity of comorbid illness, not arrhythmia

12. Special Clinical Points

  • MAT is often a marker of severe illness
  • Always look for hypoxia or lung pathology
  • Misdiagnosis as atrial fibrillation can lead to inappropriate anticoagulation

13. Exam-Oriented Summary

  • Elderly + COPD + irregular tachycardia → think MAT
  • ≥ 3 P-wave morphologies
  • Treat cause first, not the rhythm
  • Magnesium and calcium channel blockers are mainstays

⚡ Interactive MCQ Quiz

MCQ Exam Mode

15 Questions
Question 1 of 15
Answer all questions then submit.

Frequently Asked Questions

Multifocal atrial tachycardia is a supraventricular tachyarrhythmia characterized by an irregular rhythm, heart rate greater than 100 beats per minute, and at least three different P-wave morphologies on ECG, caused by multiple ectopic atrial pacemakers.
The most common cause of multifocal atrial tachycardia is hypoxia, most frequently seen in patients with chronic obstructive pulmonary disease or acute pulmonary illnesses.
MAT is diagnosed on ECG by the presence of an irregularly irregular rhythm, heart rate over 100 per minute, at least three distinct P-wave morphologies, variable PR intervals, and an isoelectric baseline between P waves.
MAT shows discrete P waves with different morphologies and an isoelectric baseline, whereas atrial fibrillation has no distinct P waves and shows continuous fibrillatory activity.
Wandering atrial pacemaker has similar ECG features to MAT but the heart rate is less than 100 beats per minute, whereas MAT has a heart rate greater than 100 beats per minute.
The most important step is treatment of the underlying cause, such as correcting hypoxia, treating pulmonary disease, managing infection, and correcting electrolyte abnormalities.
Magnesium sulfate and non-dihydropyridine calcium channel blockers such as verapamil or diltiazem are preferred for rate control in MAT.
Beta blockers are generally avoided or used cautiously because many MAT patients have underlying COPD or asthma, where beta blockers may worsen bronchospasm.
No, electrical cardioversion is ineffective in MAT because the arrhythmia is due to enhanced automaticity rather than a re-entrant mechanism.
No, anticoagulation is not indicated in multifocal atrial tachycardia as it does not increase the risk of thromboembolism.
Hypokalemia and hypomagnesemia are commonly associated with MAT and should be corrected promptly.
No, digoxin is generally ineffective in MAT and may worsen the arrhythmia due to increased atrial automaticity.
Drugs such as theophylline, beta-agonists, and excess catecholamines can precipitate or worsen MAT.
The prognosis depends on the severity of the underlying illness; MAT itself is usually benign but is often a marker of severe systemic or pulmonary disease.
MAT is most commonly seen in elderly patients with severe pulmonary disease, particularly chronic obstructive pulmonary disease.
Related Topics
multifocal atrial tachycardia ECG criteria multifocal atrial tachycardia causes and management difference between MAT and atrial fibrillation multifocal atrial tachycardia in COPD patients treatment of multifocal atrial tachycardia with magnesium why cardioversion is ineffective in MAT irregularly irregular tachycardia with p waves multifocal atrial tachycardia diagnosis steps drugs used in multifocal atrial tachycardia prognosis of multifocal atrial tachycardia MAT arrhythmia clinical features wandering atrial pacemaker vs MAT multifocal atrial tachycardia MAT arrhythmia multifocal atrial tachycardia ECG MAT diagnosis MAT management supraventricular tachycardia causes irregular narrow complex tachycardia atrial tachycardia multiple p waves MAT vs atrial fibrillation arrhythmia in COPD hypoxia induced arrhythmia magnesium treatment MAT calcium channel blockers MAT
More in medicine
Congestive Heart Failure Comprehensive Guide Diagnosis Classification and Management
Congestive Heart Failure Comprehensive Guide Diagnosis Classification and Management
medicine
Hyperthyroidism Clinical Guide Diagnosis Causes Symptoms Treatment
Hyperthyroidism Clinical Guide Diagnosis Causes Symptoms Treatment
medicine
Bundle Branch Block Clinical Features Diagnosis and Management Guide
Bundle Branch Block Clinical Features Diagnosis and Management Guide
medicine
Pulseless Electrical Activity Clinical Features Diagnosis and Management Guide
Pulseless Electrical Activity Clinical Features Diagnosis and Management Guide
medicine
Cushing Syndrome Comprehensive Clinical Guide Diagnosis Causes and Management
Cushing Syndrome Comprehensive Clinical Guide Diagnosis Causes and Management
medicine
Ischemic Heart Disease Comprehensive Clinical Guide Diagnosis Management and Prevention
Ischemic Heart Disease Comprehensive Clinical Guide Diagnosis Management and Prevention
medicine
Browse Specialties
Related Articles
Congestive Heart Failure Comprehensive Guide Diagnosis Classification and Management
medicine
Hyperthyroidism Clinical Guide Diagnosis Causes Symptoms Treatment
medicine
Bundle Branch Block Clinical Features Diagnosis and Management Guide
medicine
Pulseless Electrical Activity Clinical Features Diagnosis and Management Guide
medicine
Popular Tags
first heart sound S1 ADHD in children complications of third stage of labour third stage of labour complications postpartum hemorrhage causes retained placenta management uterine inversion obstetrics placenta accreta spectrum active management of third stage of labour PPH prevention obstetric emergencies third stage embryology head and neck blood supply of upper limb upper limb anatomy mitral regurgitation valvular heart disease percutaneous coronary intervention pci procedure coronary angioplasty pci indications